Kennedy Capital Management’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.5M Sell
182,871
-3,450
-2% -$60K 0.06% 377
2026
Q1
$2.96M Buy
186,321
+4,578
+3% +$80K 0.06% 373
2025
Q4
$3.23M Buy
181,743
+16,230
+10% +$284K 0.07% 369
2025
Q3
$3.07M Sell
165,513
-23,511
-12% -$484K 0.07% 377
2025
Q2
$4.06M Sell
189,024
-11,009
-6% -$238K 0.1% 327
2025
Q1
$4.93M Sell
200,033
-49,945
-20% -$1.23M 0.12% 289
2024
Q4
$5.79M Buy
249,978
+141,174
+130% +$3.53M 0.13% 284
2024
Q3
$2.95M Buy
108,804
+3,561
+3% +$108K 0.07% 429
2024
Q2
$3.03M Buy
105,243
+6,006
+6% +$184K 0.06% 446
2024
Q1
$2.89M Buy
+99,237
New +$2.77M 0.06% 453

Other funds holding KIDS

Kennedy Capital Management's KIDS Position: Q2 2026 in Review

Kennedy Capital Management reduced its OrthoPediatrics (KIDS) stake by 1.9% in Q2 2026, selling an estimated $60K and leaving 182,871 shares worth $3.5M. The position accounts for 0.06% of the portfolio, ranked #377.

Kennedy Capital Management first reported a position in KIDS in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.79M in Q4 2024. 120 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

  • Kennedy Capital Management held 182,871 shares of OrthoPediatrics worth $3.5M as of Q2 2026.
  • Kennedy Capital Management sold 3,450 OrthoPediatrics shares in Q2 2026, an estimated $60K.
  • OrthoPediatrics made up 0.06% of Kennedy Capital Management's portfolio in Q2 2026, its #377 holding.
  • Kennedy Capital Management first reported a position in OrthoPediatrics in Q1 2024 and has held it in 10 quarters since.
  • Kennedy Capital Management's OrthoPediatrics position peaked at $5.79M in Q4 2024.
  • 120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.